Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. completed
Appointed director

Cosmos Health Inc. (COSM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 8-K Quarterly results
10/03/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
08/23/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/18/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/15/2023 4 Aslidis Anastasios (Director) has filed a Form 4 on Cosmos Health Inc.
Txns: Granted 20,000 shares @ $0.001, valued at $20
08/15/2023 8-K Quarterly results
Docs: "Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $ Million H1 2022; Book Value per Share Exceeds $4.04 CHICAGO, IL / August 15, 2023 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported its financial results for the second quarter of 2023. Q2 and H1 2023 Financial Highlights"
08/15/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Letter from Armanino LLP regarding change in independent registered public accounting firm"
08/04/2023 4 Ziegler Manfred (Director) has filed a Form 4 on Cosmos Health Inc.
Txns: Granted 5,000 shares @ $0.001, valued at $5
08/04/2023 3 Ziegler Manfred (Director) has filed a Form 3 on Cosmos Health Inc.
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 4 Ignatiades Pavlos (Chief Communications Officer) has filed a Form 4 on Cosmos Health Inc.
Txns: Granted 5,000 shares @ $0.001, valued at $5
07/27/2023 D Form D - Notice of Exempt Offering of Securities:
07/25/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/25/2023 8-K Quarterly results
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/21/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/06/2023 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "SOURCE:"
06/07/2023 4 Siokas Grigorios (CEO) has filed a Form 4 on Cosmos Health Inc.
Txns: Bought 4,474 shares @ $23.92, valued at $107k
05/31/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Binding Letter of Intent by and among Cosmos Health Inc. and Docpharm GmbH and Dr. Mathias Krebs"
05/16/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Stock Purchase Agreement by and among Cosmos Health Inc. and Konstantinos-Gaston Kanaroglou and Konstantina-Mathilde Kanaroglou regarding Cana Laboratories Holding (Cyprus) Limited"
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 8-K Quarterly results
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Secured Promissory Note issued by Cana Laboratories Holdings (Cyprus) Limited",
"Cana Holdings Share Pledge Agreement",
"Cana Pharmaceutical Share Pledge Agreement"
02/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Press Release titled “Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer”"
01/30/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/27/2023 4/A Siokas Grigorios (CEO) has filed a Form 4 on Cosmos Health Inc.
Txns: Bought 260,870 shares @ $11.5, valued at $3M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy